Detalhe da pesquisa
1.
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.
PLoS Pathog
; 12(1): e1005356, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26808628
2.
Listeria-Vectored Vaccine Expressing the Mycobacterium tuberculosis 30-Kilodalton Major Secretory Protein via the Constitutively Active prfA* Regulon Boosts Mycobacterium bovis BCG Efficacy against Tuberculosis.
Infect Immun
; 85(9)2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28630063
3.
Redox-Triggered Release of Moxifloxacin from Mesoporous Silica Nanoparticles Functionalized with Disulfide Snap-Tops Enhances Efficacy Against Pneumonic Tularemia in Mice.
Small
; 12(27): 3690-702, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27246117
4.
pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice.
Small
; 11(38): 5066-78, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26193431
5.
Tuberculosis: pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in Mice (Small 38/2015).
Small
; 11(38): 5065, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450161
6.
A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Infect Immun
; 81(5): 1550-61, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439306
7.
Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models.
bioRxiv
; 2022 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233569
8.
A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Infect Immun
; 78(10): 4341-55, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20643859
9.
Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
PLoS One
; 14(5): e0215607, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31075149
10.
Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model.
ACS Infect Dis
; 5(2): 281-291, 2019 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480992
11.
Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.
Sci Rep
; 8(1): 7009, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29725025
12.
Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibility.
PLoS One
; 13(11): e0207469, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427938
13.
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.
Nat Commun
; 8: 14183, 2017 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28117835
14.
Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Vaccine
; 34(41): 4969-4978, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27577555
15.
Mesoporous Silica Nanoparticles with pH-Sensitive Nanovalves for Delivery of Moxifloxacin Provide Improved Treatment of Lethal Pneumonic Tularemia.
ACS Nano
; 9(11): 10778-89, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26435204
16.
Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis.
Vaccine
; 27(3): 441-5, 2009 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19007841
17.
Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
Vaccine
; 24(4): 443-51, 2006 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-16125825
18.
A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG.
Vaccine
; 24(10): 1593-600, 2006 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-16257099
19.
Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein.
Infect Immun
; 73(8): 4676-83, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16040980